Roth Capital Reiterates Buy on SkinHealth Systems, Lowers Price Target to $2
Benzinga Newsdesk 5 months ago
NewsPrice TargetReiterationAnalyst Ratings
Roth Capital analyst George Kelly reiterates SkinHealth Systems (NASDAQ:SKIN) with a Buy and lowers the price target from $2.5 to $2.
Roth Capital analyst George Kelly reiterates SkinHealth Systems (NASDAQ:SKIN) with a Buy and lowers the price target from $2.5 to $2.